skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience
Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience

Hicham Skali Hans-Henrik Parving; Patrick S Parfrey; Emmanuel A Burdmann; Eldrin F Lewis; Peter Ivanovich; Sai Ram Keithi-Reddy; Janet B McGill; John J. V McMurray; Ajay K Singh; Scott D Solomon; Hajime Uno; Marc A Pfeffer

Circulation Baltimore v. 124, n. 25, p. 2903-2908, 2011

Baltimore 2011

Acesso online. A biblioteca também possui exemplares impressos.

2
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

Finnian R. Mc Causland Brian Claggett; Marc A Pfeffer; Emmanuel de Almeida Burdmann; Kai-Uwe Eckardt; Andrew S Levey; John J. V McMurray; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert D Toto; Patrick Parfrey

American journal of nephrology v. 46, n. 6, p. 488-497, 2017

Basel 2017

Localização: FM - Fac. Medicina    (BCSEP 562 2017 )(Acessar)

3
Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Gregory G. Schwartz Anders G Olsson; Christie M Ballantyne; Phillip J Barter; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J. V McMurray; Prediman K Shah; Jean-Claude Tardif; Bernard R Chaitman; Regina Duttlinger Maddux; John Mathieson; Antonio Haddad

American Heart Journal Philadelphia v. 158, n. 6, p. 896-901.e3, 2009

Philadelphia 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2177357 estantes deslizantes )(Acessar)

4
Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rationale and design of the sal-Outcommes trial efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Gregory G. Schwartz Anders G Olsson; Christie M Ballantyne; Phillip J Barter; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J. V McMurray; Prediman K Shah; Jean-Claude Tardif; Bernard R Chaitman; Regina Duttlinger Maddux; John Mathieson; Antonio Haddad

American Heart Journal Philadelphia v. 158, n. 6, p. 896-901.e3, 2009

Philadelphia 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2177357 estantes deslizantes )(Acessar)

5
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Material Type:
Artigo 		Adicionar ao Meu Espaço

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

Marc A. Pfeffer John J. V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Kober; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf; José Antônio Marin-Neto

New England Journal of Medicine Boston v. 349, p. 1893-1906, 2003

Boston 2003

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1358214 )(Acessar)

6
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Material Type:
Artigo 		Adicionar ao Meu Espaço

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

Marc A. Pfeffer John J. V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Kober; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf; José Antônio Marin-Neto

New England Journal of Medicine Boston v. 349, p. 1893-1906, 2003

Boston 2003

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1358214 )(Acessar)

7
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Material Type:
Artigo 		Adicionar ao Meu Espaço

Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

Rajesh Janardhanan Satish Kenchaiah; Eric J Velazquez; Yuhyun Park; John J. V McMurray; W. Douglas Weaver; Peter V Finn; Harvey D White; José Antônio Marin-Neto; Chris O'Connor; Marc A Pfeffer; Robert M Calif; Scott D Solomon

American Heart Journal St. Louis v. 152, n. 1, p. 183-189, 2006

St. Louis 2006

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1585544 )(Acessar)

8
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Material Type:
Artigo 		Adicionar ao Meu Espaço

Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

Rajesh Janardhanan Satish Kenchaiah; Eric J Velazquez; Yuhyun Park; John J. V McMurray; W. Douglas Weaver; Peter V Finn; Harvey D White; José Antônio Marin-Neto; Chris O'Connor; Marc A Pfeffer; Robert M Calif; Scott D Solomon

American Heart Journal St. Louis v. 152, n. 1, p. 183-189, 2006

St. Louis 2006

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1585544 )(Acessar)

9
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction

Harvey D. White Philip E. G Aylward; Zhen Huang; Anthony Dalby; Douglas Weaver; Stale Barvik; José Antônio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H. van Gilst; Faiez Zannad; John J. V McMurray; Robert M Califf; Marc A Pfeffer

Circulation Baltimore v. 29, p. 3391-3399, 2005

Baltimore 2005

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1501773 )(Acessar)

10
Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF)
Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF)

John J. V. McMurray Inder S Anand; Rafael Diaz; Aldo P Maggioni; Christopher O’Connor; Marc A Pfeffer; Scott D Solomon; Michal Tendera; Dirk J. van Veldhuisen; Moetaz Albizem; Sunfa Cheng; Debra Scarlata; Karl Swedberg; James B Young; Marcus Vinícius Simões; RED-HF Trial Investigators

European Journal of Heart Failure Oxford v. 15, n. 3, p. 334\2013341, 2013

Oxford 2013

Localização: FM - Fac. Medicina    (OPI 33052 2019 ) e outros locais(Acessar)

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.433)
  2. Imagens  (30)
  3. Anais de Congresso  (2)
  4. Book Chapters  (2)
  5. magazinearticle  (1)
  6. Livros  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2001  (36)
  2. 2001Até2006  (152)
  3. 2007Até2012  (263)
  4. 2013Até2019  (452)
  5. Após 2019  (570)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.464)
  2. Japonês  (156)
  3. Russo  (9)
  4. Norueguês  (7)
  5. Turco  (2)
  6. Espanhol  (2)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.